Hospira Methotrexate Injection USP 50 mg/2 mL vial

Страна: Австралия

Язык: английский

Источник: Department of Health (Therapeutic Goods Administration)

Активный ингредиент:

sodium chloride, Quantity: 2.6 mg/mL; methotrexate, Quantity: 25 mg/mL

Доступна с:

Hospira Australia Pty Ltd

ИНН (Международная Имя):

Methotrexate,sodium chloride

Фармацевтическая форма:

Injection

состав:

Excipient Ingredients: benzyl alcohol; sodium hydroxide; water for injections; hydrochloric acid

Администрация маршрут:

Intraarterial, Intravenous, Intramuscular

Штук в упаковке:

5 x 2 mL vials

класс:

Medicine Listed (Export Only)

Тип рецепта:

(S1) This Schedule is intentionally blank

Терапевтические показания :

Methotrexate Injection USP belongs to a group of medicines known as anti-metabolites. It is used in high doses to treat certain types of cancers, including breast cancer, Non-Hodgkin's lymphoma and leukemia. At lower doses, it may also be used to treat severe psoriasis and severe rheumatoid arthritis.

Обзор продуктов:

Visual Identification: A yellow solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 30 Months; Container Temperature: Store between 15-25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Статус Авторизация:

Licence status A

Дата Авторизация:

2007-09-13